Jump to content
  • Announcements

    • olyclimber

      WELCOME TO THE CASCADECLIMBERS.COM FORUMS   02/03/18

      We have upgraded to new forum software as of late last year, and it makes everything here so much better!  It is now much easier to do pretty much anything, including write Trip Reports, sell gear, schedule climbing related events, and more. There is a new reputation system that allows for positive contributors to be recognized,  it is possible to tag content with identifiers, drag and drop in images, and it is much easier to embed multimedia content from Youtube, Vimeo, and more.  In all, the site is much more user friendly, bug free, and feature rich!   Whether you're a new user or a grizzled cascadeclimbers.com veteran, we think you'll love the new forums. Enjoy!
Sign in to follow this  
iluka

Looking for Climbers Who've Attempted Mt. Everest

Recommended Posts

Exposure to high altitude poses a risk of developing one of three forms of acute altitude illness: acute mountain sickness, high altitude cerebral edema and high altitude pulmonary edema. Medications are available to prevent these problems and are commonly used by travelers at moderate elevations (e.g., 3000-5000 m) for this purpose. Recent reports suggest that climbers traveling to extremely high elevations on Mount Everest and other peaks are also using these medications to improve physical performance and/or increase their odds of reaching the summit without developing altitude illness. Despite these reports, little is known about exactly how common these practices are.

 

We are conducting a research survey in order to estimate the number of climbers on Mount Everest who are using medications in this manner. People who have attempted to climb Mount Everest – whether they were successful in summiting or not – are eligible to participate. If are eligible and choose to participate, you will find a link to the anonymous on-line survey at the bottom of this email. The survey will less than 20 minutes to complete and does not require you to provide any personal information.

 

Participation in this study is voluntary. You may decline to answer any question in the survey. All of the information you provide in the survey will remain anonymous and no one will be able to identify you from the information you provide in the survey. Although you will not benefit directly from this survey, we anticipate that information learned from the survey will help guide medical practice with regard to climbers on Mount Everest and other large Himalayan mountains.

 

If you have any questions, feel free to email us at aluks@u.washington.edu, although please be reminded that the confidentiality of emails cannot be guaranteed. We appreciate your time and effort in completing this survey and look forward to reviewing the information you provide.

 

Click here to complete this survey: https://catalyst.uw.edu/webq/survey/aluks/252982

 

If the link does not work, you can copy and paste it in your web browser.

 

PLEASE REMEMBER TO CLICK ON "SUBMIT" AT THE END OF THE SURVEY TO ENSURE THAT YOUR ANSWERS ARE ALL SAVED PROPERLY.

 

Sincerely,

 

Andrew M. Luks, MD

Associate Professor, Pulmonary and Critical Care Medicine

University of Washington

 

Luanne Freer, MD

Everest ER

Himalayan Rescue Association

 

Colin Grissom, MD

Professor of Medicine

University of Utah

 

Peter Hackett, MD

Institute for High Altitude Medicine

Telluride, Colorado

 

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

Sign in to follow this  

×